Multiple randomized prospective trials have failed to show a definitive survival advantage for the administration of adjuvant therapy following complete resection of non small-cell lung cancer.
| UI | MeSH Term | Description | Entries |
|---|
Multiple randomized prospective trials have failed to show a definitive survival advantage for the administration of adjuvant therapy following complete resection of non small-cell lung cancer.
| UI | MeSH Term | Description | Entries |
|---|